Welcome to LookChem.com Sign In|Join Free
  • or
Methyl 5-bromo-1H-imidazole-4-carboxylate is a chemical compound characterized by the molecular formula C6H6BrN3O2. It is a derivative of imidazole, a five-membered heterocyclic ring that contains nitrogen. Methyl 5-bromo-1H-imidazole-4-carboxylate is recognized for its versatility as a building block in organic chemistry, with its functional group capable of engaging in a range of chemical reactions to create complex molecules. As a white crystalline solid, it is soluble in organic solvents and is typically managed under controlled laboratory conditions to mitigate potential health and safety risks.

1093261-46-1

Post Buying Request

1093261-46-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1093261-46-1 Usage

Uses

Used in Pharmaceutical Synthesis:
Methyl 5-bromo-1H-imidazole-4-carboxylate is utilized as an intermediate in the synthesis of pharmaceuticals. Its unique structure and reactivity make it a valuable component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Production:
In the agrochemical industry, Methyl 5-bromo-1H-imidazole-4-carboxylate serves as an intermediate for the production of various agrochemicals. Its role in this sector is crucial for the synthesis of compounds that can be used in crop protection and other agricultural applications, thereby supporting food security and crop yield enhancement.
Used in Organic Chemistry Research:
As a versatile building block, Methyl 5-bromo-1H-imidazole-4-carboxylate is also employed in organic chemistry research. It is used to explore new reaction pathways and to develop innovative synthetic methods, which can lead to the discovery of novel compounds with potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 1093261-46-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,2,6 and 1 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1093261-46:
(9*1)+(8*0)+(7*9)+(6*3)+(5*2)+(4*6)+(3*1)+(2*4)+(1*6)=141
141 % 10 = 1
So 1093261-46-1 is a valid CAS Registry Number.

1093261-46-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 5-bromo-1H-imidazole-4-carboxylate

1.2 Other means of identification

Product number -
Other names methyl 4-chloro-1H-imidazole-5-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1093261-46-1 SDS

1093261-46-1Relevant academic research and scientific papers

CONDENSED LACTAM DERIVATIVE

-

Paragraph 0487; 0488; 0489, (2020/06/27)

The present invention relates to a medicament for treating neuropsychiatric diseases, comprising a compound of Formula (1): or a pharmaceutically acceptable salt thereof, as an active ingredient.

Rational design of potent non-nucleoside inhibitors of HIV-1 reverse transcriptase

Chong, Pek,Sebahar, Paul,Youngman, Michael,Garrido, Dulce,Zhang, Huichang,Stewart, Eugene L.,Nolte, Robert T.,Wang, Liping,Ferris, Robert G.,Edelstein, Mark,Weaver, Kurt,Mathis, Amanda,Peat, Andrew

supporting information, p. 10601 - 10609 (2013/02/23)

A new series of non-nucleoside reverse transcriptase inhibitors based on an imidazole-amide biarylether scaffold has been identified and shown to possess potent antiviral activity against HIV-1, including the NNRTI-resistant Y188L mutated virus. X-ray crystallography of inhibitors bound to reverse transcriptase, including a structure of the Y188L RT protein, was used extensively to help identify and optimize the key hydrogen-bonding motif. This led directly to the design of compound 43 that exhibits remarkable antiviral activity (EC50 1 nM) against a wide range of NNRTI-resistant viruses and a favorable pharmacokinetic profile across multiple species.

CHEMICAL COMPOUNDS

-

Page/Page column 148, (2009/01/24)

The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1093261-46-1